TELETRADER News
11/25/2020, 2:20 PM
(Source: TeleTrader)
EU in talks with Russian vaccine makers - report
The European Medicines Agency (EMA) is holding discussions with the Gamaleya National Research Center for Epidemiology and Microbiology which produces the Russian COVID-19 vaccine, Sputnik reported on Wednesday citing a source from the European Commission.
However, the Russian manufacturer is yet to request permission to sell its vaccine called Sputnik V in the EU. The discussions started after the makers of the vaccine contacted the EMA, the source noted.
Earlier, the Gamaleya National Research Center for Epidemiology and Microbiology said its vaccine was over 95% effective 42 days after the first dose.